Gsk (GSK) Interest Expenses (2009 - 2026)

Gsk's Interest Expenses history runs 18 years deep, the most recent figure standing at -$301.9 million for Q2 2026.

• In Q2 2026, Interest Expenses fell 4.28% year-over-year to -$301.9 million; the TTM figure through Jun 2026 stood at -$1.2 billion (down 12.98% YoY), while the FY2025 annual figure was $924.3 million, up 8.08% from the prior year.
• Interest Expenses for Q2 2026 stood at -$301.9 million, down from -$114.6 million in the prior quarter.
• The five-year high for Interest Expenses was -$13.9 million in Q3 2023, with the low at -$919.6 million in Q4 2022.
• The 5-year median for Interest Expenses is -$282.3 million (2022), against an average of -$297.0 million.
• The sharpest annual moves came in 2022 and 2025: Interest Expenses jumped 80.71% in 2022, then sank 171.62% in 2025.
• Gsk's Interest Expenses stood at -$919.6 million in 2022, then surged by 39.53% to -$556.0 million in 2023, then retreated by 14.03% to -$634.0 million in 2024, then declined by 10.14% to -$698.3 million in 2025, then jumped by 56.77% to -$301.9 million in 2026.
• Business Quant data shows GSK's Interest Expenses at -$301.9 million in Q2 2026, -$114.6 million in Q1 2026, and -$698.3 million in Q4 2025.